Symbol | Exchange | Currency |
|---|
Investing.com - Oric Pharma (NASDAQ: ORIC) reported first quarter EPS of $-0.52, $0.04 better than the analyst estimate of $-0.56. Revenue for the quarter came in at $0.00 versus...
By Davit KirakosyanInvesting.com -- Here is your daily Pro Recap of the biggest analyst picks you may have missed on InvestingPro since yesterday.FedEx rises on Stifel upgrade to...
ORIC Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in improving patients' lives by Overcoming Resistance In Cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. Its clinical-stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens. ORIC-114, is a brain penetrant, orally bioavailable, irreversible inhibitor designed to selectively target epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) with high potency towards exon 20 insertion mutations. ORIC-944 is an allosteric inhibitor of the polycomb repressive complex 2 (PRC2).
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Neutral | Buy | Strong Buy | Sell |
| Technical Indicators | Strong Sell | Sell | Strong Buy | Strong Buy | Strong Sell |
| Summary | Strong Sell | Neutral | Strong Buy | Strong Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 197.58 | 198.00 | 188.04 | +14.33 | +7.82% | 152.86M | NASDAQ | |||
| 159.28 | 159.40 | 156.54 | +1.88 | +1.19% | 73.84M | NASDAQ | |||
| 60.32 | 60.75 | 59.88 | -0.28 | -0.46% | 13.71M | NYSE | |||
| 202.16 | 203.55 | 197.95 | +4.35 | +2.20% | 31.79M | NASDAQ | |||
| 104.92 | 105.10 | 101.22 | +3.70 | +3.66% | 42.03M | NASDAQ | |||
| 273.78 | 275.00 | 269.52 | +1.55 | +0.57% | 34.51M | NASDAQ | |||
| 40.66 | 40.91 | 40.31 | -0.15 | -0.37% | 19.97M | NYSE | |||
| 95.93 | 99.46 | 93.64 | -0.88 | -0.91% | 85.17M | NASDAQ | |||
| 100.61 | 100.85 | 98.00 | +2.90 | +2.97% | 58.46M | NASDAQ | |||
| 167.76 | 168.33 | 164.93 | +4.72 | +2.90% | 2.33M | NASDAQ | |||
| 261.99 | 263.92 | 253.81 | +2.99 | +1.15% | 54.60M | NASDAQ | |||
| 8.45 | 8.51 | 8.17 | +0.37 | +4.58% | 27.02M | NYSE | |||
| 105.84 | 105.96 | 101.86 | +3.91 | +3.84% | 33.06M | NASDAQ | |||
| 45.74 | 46.05 | 44.10 | +1.86 | +4.24% | 14.72M | NYSE | |||
| 50.67 | 51.33 | 50.33 | -0.27 | -0.53% | 23.33M | NASDAQ |